Interface management of pharmacotherapy: joint hospital and primary care drug recommendations

Linda Björkhem-Bergman, Eva Andersén-Karlsson, Richard Laing, Eduardo Diogene, Oyvind Melien, Malena Jirlow, Rickard E. Malmström, Sabine Vogler, Brian Godman, Lars L. Gustafsson

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Purpose: In September 2012 an interactive course on the "Interface Management of Pharmacotherapy" was organized by the Stockholm Drug and Therapeutics Committee in cooperation with Department of Clinical Pharmacology at Karolinska Institutet and at Karolinska University Hospital in Stockholm, Sweden, in collaboration with the WHO. The basis for the course was the "Stockholm model" for the rational use of medicines but also contained presentations about successful models in interface management of pharmacotherapy in other European countries. Methods: The "Stockholm model " consists of 8 components: 1) Independent Drug and Therapeutics Committee with key role for respected drug experts with policy for "interest of conflicts", 2) The "Wise List", recommendations of medicines jointly for primary and hospital care, 3) Communication strategy with continuous medical education, 4) Systematic introduction of new expensive medicines, 5) E-pharmacological support at "point of care", 6) Methods and tools for follow-up of medicines use, 7) Medicines policy strategy and 8) Operative resources. Results: The course highlighted the importance of efficient and targeted communication of drug recommendations building on trust among prescribers and patients for the guidelines to achieve high adherence. Trust is achieved by independent Drug and Therapeutics Committees with a key role for respected experts and a strict policy for "conflicts of interest". Representations of GPs are also crucial for successful implementation, being the link between evidence based medicine and practice. Conclusion: The successful models in Scotland and in Stockholm as well as the ongoing work in Catalonia were considered as examples of multifaceted approaches to improve the quality of medicine use across primary and hospital care.
LanguageEnglish
PagesS73-S78
Number of pages6
JournalEuropean Journal of Clinical Pharmacology
Volume69
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 3 May 2013

Fingerprint

Pharmacy and Therapeutics Committee
Primary Health Care
Joints
Drug Therapy
Pharmaceutical Preparations
Conflict of Interest
Point-of-Care Systems
Communication
Medicine
Clinical Pharmacology
Evidence-Based Practice
Evidence-Based Medicine
Scotland
Medical Education
Sweden
Pharmacology
Guidelines

Keywords

  • drug committees
  • interface management
  • pharmacoeconomics
  • rational use of medicines
  • article
  • clinical pharmacology
  • conflict of interest
  • Europe
  • evidence based medicine
  • follow up
  • health care system
  • hospital care
  • human
  • interpersonal communication
  • medical education
  • medicine
  • primary medical care
  • priority journal
  • Sweden
  • world health organization
  • drug therapy
  • pharmacy and therapeutics committee
  • primary health care
  • publication
  • theoretical model
  • university hospital
  • formularies as topic
  • university hospitals
  • humans
  • models, theoretical

Cite this

Björkhem-Bergman, L., Andersén-Karlsson, E., Laing, R., Diogene, E., Melien, O., Jirlow, M., ... Gustafsson, L. L. (2013). Interface management of pharmacotherapy: joint hospital and primary care drug recommendations. European Journal of Clinical Pharmacology, 69(SUPPL. 1), S73-S78. https://doi.org/10.1007/s00228-013-1497-5
Björkhem-Bergman, Linda ; Andersén-Karlsson, Eva ; Laing, Richard ; Diogene, Eduardo ; Melien, Oyvind ; Jirlow, Malena ; Malmström, Rickard E. ; Vogler, Sabine ; Godman, Brian ; Gustafsson, Lars L. / Interface management of pharmacotherapy : joint hospital and primary care drug recommendations. In: European Journal of Clinical Pharmacology. 2013 ; Vol. 69, No. SUPPL. 1. pp. S73-S78.
@article{0430001c3e7d4e4eace24d175c9f1b1f,
title = "Interface management of pharmacotherapy: joint hospital and primary care drug recommendations",
abstract = "Purpose: In September 2012 an interactive course on the {"}Interface Management of Pharmacotherapy{"} was organized by the Stockholm Drug and Therapeutics Committee in cooperation with Department of Clinical Pharmacology at Karolinska Institutet and at Karolinska University Hospital in Stockholm, Sweden, in collaboration with the WHO. The basis for the course was the {"}Stockholm model{"} for the rational use of medicines but also contained presentations about successful models in interface management of pharmacotherapy in other European countries. Methods: The {"}Stockholm model {"} consists of 8 components: 1) Independent Drug and Therapeutics Committee with key role for respected drug experts with policy for {"}interest of conflicts{"}, 2) The {"}Wise List{"}, recommendations of medicines jointly for primary and hospital care, 3) Communication strategy with continuous medical education, 4) Systematic introduction of new expensive medicines, 5) E-pharmacological support at {"}point of care{"}, 6) Methods and tools for follow-up of medicines use, 7) Medicines policy strategy and 8) Operative resources. Results: The course highlighted the importance of efficient and targeted communication of drug recommendations building on trust among prescribers and patients for the guidelines to achieve high adherence. Trust is achieved by independent Drug and Therapeutics Committees with a key role for respected experts and a strict policy for {"}conflicts of interest{"}. Representations of GPs are also crucial for successful implementation, being the link between evidence based medicine and practice. Conclusion: The successful models in Scotland and in Stockholm as well as the ongoing work in Catalonia were considered as examples of multifaceted approaches to improve the quality of medicine use across primary and hospital care.",
keywords = "drug committees, interface management, pharmacoeconomics, rational use of medicines, article, clinical pharmacology, conflict of interest, Europe, evidence based medicine, follow up, health care system, hospital care, human, interpersonal communication, medical education, medicine, primary medical care, priority journal, Sweden, world health organization, drug therapy, pharmacy and therapeutics committee, primary health care, publication, theoretical model, university hospital, formularies as topic, university hospitals, humans, models, theoretical",
author = "Linda Bj{\"o}rkhem-Bergman and Eva Anders{\'e}n-Karlsson and Richard Laing and Eduardo Diogene and Oyvind Melien and Malena Jirlow and Malmstr{\"o}m, {Rickard E.} and Sabine Vogler and Brian Godman and Gustafsson, {Lars L.}",
year = "2013",
month = "5",
day = "3",
doi = "10.1007/s00228-013-1497-5",
language = "English",
volume = "69",
pages = "S73--S78",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
number = "SUPPL. 1",

}

Björkhem-Bergman, L, Andersén-Karlsson, E, Laing, R, Diogene, E, Melien, O, Jirlow, M, Malmström, RE, Vogler, S, Godman, B & Gustafsson, LL 2013, 'Interface management of pharmacotherapy: joint hospital and primary care drug recommendations' European Journal of Clinical Pharmacology, vol. 69, no. SUPPL. 1, pp. S73-S78. https://doi.org/10.1007/s00228-013-1497-5

Interface management of pharmacotherapy : joint hospital and primary care drug recommendations. / Björkhem-Bergman, Linda; Andersén-Karlsson, Eva; Laing, Richard; Diogene, Eduardo; Melien, Oyvind; Jirlow, Malena; Malmström, Rickard E.; Vogler, Sabine; Godman, Brian; Gustafsson, Lars L.

In: European Journal of Clinical Pharmacology, Vol. 69, No. SUPPL. 1, 03.05.2013, p. S73-S78.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Interface management of pharmacotherapy

T2 - European Journal of Clinical Pharmacology

AU - Björkhem-Bergman, Linda

AU - Andersén-Karlsson, Eva

AU - Laing, Richard

AU - Diogene, Eduardo

AU - Melien, Oyvind

AU - Jirlow, Malena

AU - Malmström, Rickard E.

AU - Vogler, Sabine

AU - Godman, Brian

AU - Gustafsson, Lars L.

PY - 2013/5/3

Y1 - 2013/5/3

N2 - Purpose: In September 2012 an interactive course on the "Interface Management of Pharmacotherapy" was organized by the Stockholm Drug and Therapeutics Committee in cooperation with Department of Clinical Pharmacology at Karolinska Institutet and at Karolinska University Hospital in Stockholm, Sweden, in collaboration with the WHO. The basis for the course was the "Stockholm model" for the rational use of medicines but also contained presentations about successful models in interface management of pharmacotherapy in other European countries. Methods: The "Stockholm model " consists of 8 components: 1) Independent Drug and Therapeutics Committee with key role for respected drug experts with policy for "interest of conflicts", 2) The "Wise List", recommendations of medicines jointly for primary and hospital care, 3) Communication strategy with continuous medical education, 4) Systematic introduction of new expensive medicines, 5) E-pharmacological support at "point of care", 6) Methods and tools for follow-up of medicines use, 7) Medicines policy strategy and 8) Operative resources. Results: The course highlighted the importance of efficient and targeted communication of drug recommendations building on trust among prescribers and patients for the guidelines to achieve high adherence. Trust is achieved by independent Drug and Therapeutics Committees with a key role for respected experts and a strict policy for "conflicts of interest". Representations of GPs are also crucial for successful implementation, being the link between evidence based medicine and practice. Conclusion: The successful models in Scotland and in Stockholm as well as the ongoing work in Catalonia were considered as examples of multifaceted approaches to improve the quality of medicine use across primary and hospital care.

AB - Purpose: In September 2012 an interactive course on the "Interface Management of Pharmacotherapy" was organized by the Stockholm Drug and Therapeutics Committee in cooperation with Department of Clinical Pharmacology at Karolinska Institutet and at Karolinska University Hospital in Stockholm, Sweden, in collaboration with the WHO. The basis for the course was the "Stockholm model" for the rational use of medicines but also contained presentations about successful models in interface management of pharmacotherapy in other European countries. Methods: The "Stockholm model " consists of 8 components: 1) Independent Drug and Therapeutics Committee with key role for respected drug experts with policy for "interest of conflicts", 2) The "Wise List", recommendations of medicines jointly for primary and hospital care, 3) Communication strategy with continuous medical education, 4) Systematic introduction of new expensive medicines, 5) E-pharmacological support at "point of care", 6) Methods and tools for follow-up of medicines use, 7) Medicines policy strategy and 8) Operative resources. Results: The course highlighted the importance of efficient and targeted communication of drug recommendations building on trust among prescribers and patients for the guidelines to achieve high adherence. Trust is achieved by independent Drug and Therapeutics Committees with a key role for respected experts and a strict policy for "conflicts of interest". Representations of GPs are also crucial for successful implementation, being the link between evidence based medicine and practice. Conclusion: The successful models in Scotland and in Stockholm as well as the ongoing work in Catalonia were considered as examples of multifaceted approaches to improve the quality of medicine use across primary and hospital care.

KW - drug committees

KW - interface management

KW - pharmacoeconomics

KW - rational use of medicines

KW - article

KW - clinical pharmacology

KW - conflict of interest

KW - Europe

KW - evidence based medicine

KW - follow up

KW - health care system

KW - hospital care

KW - human

KW - interpersonal communication

KW - medical education

KW - medicine

KW - primary medical care

KW - priority journal

KW - Sweden

KW - world health organization

KW - drug therapy

KW - pharmacy and therapeutics committee

KW - primary health care

KW - publication

KW - theoretical model

KW - university hospital

KW - formularies as topic

KW - university hospitals

KW - humans

KW - models, theoretical

UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-84886732448&partnerID=40&md5=347123084e9455125b76399b79b56ea0

U2 - 10.1007/s00228-013-1497-5

DO - 10.1007/s00228-013-1497-5

M3 - Article

VL - 69

SP - S73-S78

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - SUPPL. 1

ER -

Björkhem-Bergman L, Andersén-Karlsson E, Laing R, Diogene E, Melien O, Jirlow M et al. Interface management of pharmacotherapy: joint hospital and primary care drug recommendations. European Journal of Clinical Pharmacology. 2013 May 3;69(SUPPL. 1):S73-S78. https://doi.org/10.1007/s00228-013-1497-5